Sanaregen™ Vision Therapeutics Revenue

Biotechnology Research • 1831 12th Ave S, Suite 252, United States • 1-10 Employees

Sanaregen™ Vision Therapeutics revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Sanaregen™ Vision Therapeutics

Doug Oliver

Founder

Company overview

Headquarters	1831 12th Ave S, Suite 252, Nashville, Tennessee 37204, US
Website	sanaregenvision.com
NAICS	541714
Keywords	Macular Degeneration, Regenerative Medicine, Stem Cells, Vision Restoration, Geographic Atrophy, Degenerative Retinal Disease, Retinopathies
Founded	2024
Employees	1-10

About Sanaregen™ Vision Therapeutics

Sanaregen Vision Therapeutics, Inc. is a clinical-stage biopharmaceutical research and development company that is developing one of the first regenerative medicine treatments designed to effectively treat degenerative retinal diseases. With creative trial design, iterative development, and platform technology with multimodal capabilities, we create potential for accelerated approvals and first-to-market positioning.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Sanaregen™ Vision Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Sanaregen™ Vision Therapeutics has never raised funding before.

Frequently asked questions

Sanaregen™ Vision Therapeutics is located in 1831 12th Ave S, Suite 252, US.

Sanaregen™ Vision Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Sanaregen™ Vision Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Sanaregen™ Vision Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Sanaregen™ Vision Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Sanaregen™ Vision Therapeutics

Doug Oliver

Founder

4.8

40,000 users